Metformin is the key factor for elevated plasma GDF ‐15 levels in type 2 diabetes: a nested, case‐control study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Andrea
Natali
,
Lorenzo
Nesti
,
Elena
Venturi
,
Angela C.
Shore
,
Faisel
Khan
,
Kim
Gooding
,
Phillip E.
Gates
,
Helen C
Looker
,
Fiona
Dove
,
Isabel
Goncalves
,
Margaretha
Persson
,
Jan
Nilsson
, Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fortamet | Metformin | Obesity | Study